Thermo Fisher Scientific (TMO) Consolidated Net Income (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Consolidated Net Income for 18 consecutive years, with $1.7 billion the latest figure, recorded in Q1 2026.

• Consolidated Net Income for Q1 2026 came in at $1.7 billion, up 9.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.9 billion (up 4.61% YoY), and the FY2025 annual result was $6.8 billion, up 5.97% from the prior year.
• Consolidated Net Income was $1.7 billion for Q1 2026 at Thermo Fisher Scientific, down from $2.0 billion in the prior quarter.
• Over five years, Consolidated Net Income peaked at $2.2 billion in Q2 2022 and troughed at $1.3 billion in Q1 2024.
• Average Consolidated Net Income over 5 years is $1.6 billion, with a median of $1.6 billion recorded in 2025.
• Year-over-year, Consolidated Net Income tumbled 41.18% in 2023 and rose 18.8% in 2024.
• Over 5 years, Consolidated Net Income stood at $1.6 billion in 2022, then grew by 0.19% to $1.6 billion in 2023, then grew by 11.45% to $1.8 billion in 2024, then rose by 11.67% to $2.0 billion in 2025, then dropped by 16.8% to $1.7 billion in 2026.
• Per Business Quant data, the three most recent Consolidated Net Income figures were $1.7 billion in Q1 2026, $2.0 billion in Q4 2025, and $1.6 billion in Q3 2025.